1. KatohI, YoshinakaY, ReinA, ShibuyaM, OdakaT, et al. (1985) Murine leukemia virus maturation: protease region required for conversion from “immature” to “mature” core form and for virus infectivity. Virology 145: 280–292.
2. de MarcoA, MullerB, GlassB, RichesJD, KrausslichHG, et al. (2010) Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog 6: e1001215.
3. WaheedAA, FreedEO (2012) HIV type 1 Gag as a target for antiviral therapy. Aids Research and Human Retroviruses 28: 54–75.
4. JohnsonVA, CalvezV, GunthardHF, ParedesR, PillayD, et al. (2013) Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med 21: 6–14.
5. FassatiA (2012) Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res 170: 15–24.
6. HilditchL, TowersGJ (2014) A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr Opin Virol 4: 32–36.
7. AmbroseZ, AikenC (2014) HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. Virology 454–455: 371–379.
8. YuanB, LiX, GoffSP (1999) Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. The EMBO Journal 18: 4700–4710.
9. Martin-SerranoJ, EastmanSW, ChungW, BieniaszPD (2005) HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. Journal of Cell Biology 168: 89–101.
10. WightDJ, BoucheritVC, NaderM, AllenDJ, TaylorIA, et al. (2012) The gammaretroviral p12 protein has multiple domains that function during the early stages of replication. Retrovirology 9: 83.
11. YuanB, FassatiA, YuehA, GoffSP (2002) Characterization of Moloney Murine Leukemia Virus p12 Mutants Blocked during Early Events of Infection. Journal of Virology 76: 10801–10810.
12. Prizan-RavidA, ElisE, Laham-KaramN, SeligS, EhrlichM, et al. (2010) The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex. PLoS Pathog 6: e1001183.
13. SchneiderWM, BrzezinskiJD, AiyerS, MalaniN, GyuriczaM, et al. (2013) Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. Proc Natl Acad Sci U S A 110: 9487–9492.
14. ElisE, EhrlichM, Prizan-RavidA, Laham-KaramN, BacharachE (2012) p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog 8: e1003103.
15. WuX, LiY, CriseB, BurgessSM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749–1751.
16. MitchellRS, BeitzelBF, SchroderAR, ShinnP, ChenH, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
17. BerryC, HannenhalliS, LeipzigJ, BushmanFD (2006) Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2: e157.
18. AiyerS, SwapnaGV, MalaniN, AraminiJM, SchneiderWM, et al. (2014) Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. Nucleic Acids Res 42: 5917–5928.
19. SharmaA, LarueRC, PlumbMR, MalaniN, MaleF, et al. (2013) BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci U S A 110: 12036–12041.
20. GuptaSS, MaetzigT, MaertensGN, SharifA, RotheM, et al. (2013) Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 87: 12721–12736.
21. De RijckJ, de KogelC, DemeulemeesterJ, VetsS, El AshkarS, et al. (2013) The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep 5: 886–894.
22. ZhangF, ZangT, WilsonSJ, JohnsonMC, BieniaszPD (2011) Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog 7: e1002119.
23. PopovS, StrackB, Sanchez-MerinoV, PopovaE, RosinH, et al. (2011) Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag. J Virol 85: 3792–3801.
24. FassatiA, GoffSP (1999) Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J Virol 73: 8919–8925.
25. BharatTA, DaveyNE, UlbrichP, RichesJD, de MarcoA, et al. (2012) Structure of the immature retroviral capsid at 8 A resolution by cryo-electron microscopy. Nature 487: 385–389.
26. YeagerM, Wilson-KubalekEM, WeinerSG, BrownPO, ReinA (1998) Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A 95: 7299–7304.
27. BriggsJA, RichesJD, GlassB, BartonovaV, ZanettiG, et al. (2009) Structure and assembly of immature HIV. Proc Natl Acad Sci U S A 106: 11090–11095.
28. de MarcoA, DaveyNE, UlbrichP, PhillipsJM, LuxV, et al. (2010) Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol 84: 11729–11736.
29. YoshinakaY, LuftigRB (1977) Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand (“immature”) to a collapsed (“mature”) form of the virus core. Proc Natl Acad Sci U S A 74: 3446–3450.
30. YoshinakaY, LuftigRB (1977) Properties of a P70 proteolytic factor of murine leukemia viruses. Cell 12: 709–719.
31. FuW, ReinA (1993) Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol 67: 5443–5449.
32. ForsheyBM, von SchwedlerU, SundquistWI, AikenC (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76: 5667–5677.
33. FassatiA, GoffSP (2001) Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. Journal of Virology 75: 3626–3635.
34. HilditchL, MatadeenR, GoldstoneDC, RosenthalPB, TaylorIA, et al. (2011) Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc Natl Acad Sci U S A 108: 5771–5776.
35. YuehA, GoffSP (2003) Phosphorylated Serine Residues and an Arginine-Rich Domain of the Moloney Murine Leukemia Virus p12 Protein Are Required for Early Events of Viral Infection. Journal of Virology 77: 1820–1829.
36. LeeSK, NagashimaK, HuWS (2005) Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication. J Virol 79: 4159–4169.
37. AuerbachMR, BrownKR, SinghIR (2007) Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein. J Virol 81: 12337–12347.
38. BacharachE, GonskyJ, AlinK, OrlovaM, GoffSP (2000) The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly. J Virol 74: 11027–11039.
39. JuradoKA, WangH, SlaughterA, FengL, KesslJJ, et al. (2013) Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Proc Natl Acad Sci U S A 110: 8690–8695.
40. GrossI, HohenbergH, KrausslichHG (1997) In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. European Journal of Biochemistry 249: 592–600.
41. CampbellS, VogtVM (1995) Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 69: 6487–6497.
42. GanserBK, ChengA, SundquistWI, YeagerM (2003) Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J 22: 2886–2892.
43. MayoK, VanaML, McDermottJ, HusebyD, LeisJ, et al. (2002) Analysis of Rous sarcoma virus capsid protein variants assembled on lipid monolayers. J Mol Biol 316: 667–678.
44. EhrlichLS, AgrestaBE, CarterCA (1992) Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J Virol 66: 4874–4883.
45. LiS, HillCP, SundquistWI, FinchJT (2000) Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407: 409–413.
46. BaileyGD, HyunJK, MitraAK, KingstonRL (2009) Proton-linked dimerization of a retroviral capsid protein initiates capsid assembly. Structure 17: 737–748.
47. KingstonRL, Fitzon-OstendorpT, EisenmesserEZ, SchatzGW, VogtVM, et al. (2000) Structure and self-association of the Rous sarcoma virus capsid protein. Structure 8: 617–628.
48. PornillosO, Ganser-PornillosBK, BanumathiS, HuaY, YeagerM (2010) Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus. J Mol Biol 401: 985–995.
49. PornillosO, Ganser-PornillosBK, KellyBN, HuaY, WhitbyFG, et al. (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137: 1282–1292.
50. CampbellS, VogtVM (1997) In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J Virol 71: 4425–4435.
51. JoshiSM, VogtVM (2000) Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J Virol 74: 10260–10268.
52. ScheifeleLZ, KenneySP, CairnsTM, CravenRC, ParentLJ (2007) Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol 81: 10718–10728.
53. BieniaszPD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344: 55–63.
54. FreedEO (2002) Viral late domains. J Virol 76: 4679–4687.
55. YuanB, CampbellS, BacharachE, ReinA, GoffSP (2000) Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol 74: 7250–7260.
56. VottelerJ, NeumannL, HahnS, HahnF, RauchP, et al. (2011) Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly. Retrovirology 8: 11.
57. RasaiyaahJ, TanCP, FletcherAJ, PriceAJ, BlondeauC, et al. (2013) HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503: 402–405.
58. BockM, BishopKN, TowersG, StoyeJP (2000) Use of a transient assay for studying the genetic determinants of Fv1 restriction. J Virol 74: 7422–7430.
59. GroomHC, BoucheritVC, MakinsonK, RandalE, BaptistaS, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
60. MothesW, BoergerAL, NarayanS, CunninghamJM, YoungJA (2000) Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103: 679–689.
61. YapMW, NisoleS, LynchC, StoyeJP (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101: 10786–10791.
62. BruceJW, BradleyKA, AhlquistP, YoungJA (2005) Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. J Virol 79: 12969–12978.